A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase 2 clinical trial.

Welcome to our live blog tracking the latest news and developments from the United States. Stay updated with real-time ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

House Democratic Leader Hakeem Jeffries praised Zohran Mamdani’s focus on affordability after his upset mayoral primary win, while carefully avoiding endorsement of Mamdani’s democratic ...

Eli Lilly and Company (NYSE: LLY) today announced that the highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—will soon be available in single-dose vials for $499 per month ...

When Eli Lilly & Co. on Tuesday announced pricing and packaging changes for its popular weight-loss drug Zepbound, the drugmaker said it was expanding access for people living with obesity — but ...

House Minority Leader Hakeem Jeffries (D-NY) offered praise for Zohran Mamdani after his victory in the Democratic primary on Wednesday, highlighting the New York City mayoral candidate’s focus ...

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses of its blockbuster weight loss medicine Zepbound.

Zepbound is an FDA-approved injectable weight loss medication. Find out more about Zepbound for weight loss, including how it works and what experts say.

The company said the 12.5 milligrams and 15 mg doses of the drug will be available for US$499 per month on the website with shipments to self-paying patients.